OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for June, 2013

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2013-06-30 12:15 Generic Versions of AstraZenecaâÔö£é?öé??Ôö£é?ö?ñós Pulmicort Respules Enjoined from Launch Pending Appeal in Patent Infringement Case and more... 2013-06-30 00:15 Woman Disfigured by Generic Drug Loses $21 Million Award and more... 2013-06-29 00:15 Onyx Jumps After Report Amgen Considers Acquisition and more... 2013-06-28 12:15 Dendreon Surges After Cancer Drug Gets European Backing and more... 2013-06-28 00:15 FDA approves new Baxter drug for hemophilia B and more... 2013-06-27 12:15 Novo Nordisk Suspends Paula Deen As A Spokesperson and more... 2013-06-26 12:15 Roche and AstraZeneca launch medicinal chemistry data-sharing consortium to further accelerate drug discovery and more... 2013-06-26 00:15 New drugs allow GSK disposals to 'far exceed' acquisitions and more... 2013-06-25 12:15 FDA draft guidance on generic eye drug push Allergen shares lower and more... 2013-06-25 00:15 Sonendo closes on $27M for root canal device and more... 2013-06-24 12:15 FDA puts Cell Therapeutics blood cancer drug on hold after death and more... 2013-06-24 00:15 Justice Department Sues Sage Pharmaceuticals Inc. and more... 2013-06-22 12:15 Merck backs Medivo in $15M in Series B round and more... 2013-06-21 12:15 10 Top-selling Diabetes Drugs - 2012 and more... 2013-06-21 00:15 Teva reportedly set to sell generic Viagra in Europe and more... 2013-06-20 12:15 Pipeline Vs. Expiring Patents: Eli Lilly's Future and more... 2013-06-20 00:15 Biogen's impressive Tecfidera launch hits reimbursement, supply snags and more... 2013-06-19 12:15 Zoetis Exchange Offer Update and more... 2013-06-19 00:15 Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs and more... 2013-06-18 12:15 Osiris - Can Stem Cells Lead To Profits? and more... 2013-06-18 00:15 With $135M rights deal, Questcor locks up rival to its pricey Acthar drug and more... 2013-06-17 12:15 Rexahn awarded U.S. patent for novel anti-cancer compounds and more... 2013-06-17 00:15 Biotechs Lose Ground As Achillion Takes a Dive and more... 2013-06-16 12:15 Abbott Declares Dividend and $3 Billion Buyback Plan and more... 2013-06-16 00:15 Is Johnson & Johnson A Buy At These Prices? and more... 2013-06-15 00:15 Penny-Wise, Pound-Foolish Stem Cell Stocks and more... 2013-06-14 12:15 These Mutated Cystic Fibrosis Cells Are Worth Billions to Vertex Pharma and more... 2013-06-14 00:15 Medical-Device Makers Urged by FDA to Boost Cybersecurity and more... 2013-06-13 12:15 Inside HCV: An Interview with Janssen and more... 2013-06-13 00:15 Elan Risking $2 Billion If Royalty Pharma Walks: Real M&A and more... 2013-06-12 12:15 Aveo defends kidney cancer drug rejected by the FDA and more... 2013-06-12 00:15 [video]The Obesity-Drug Wars Officially Begin and more... 2013-06-11 12:15 Potential ViroPharma drug receives orphan status and more... 2013-06-11 00:15 Glaxo Dismisses Exec Over Fabricated Data & Retraction Is Sought and more... 2013-06-10 12:15 CelgeneâÔö£é?öé??Ôö£é?ö?ñós Abraxane: A Therapy for Advanced Pancreatic Cancer? and more... 2013-06-09 12:15 Teva recalls wrongly packaged sleeping pill and more... 2013-06-09 00:15 What are pharmaceutical companies looking for in a licensing deal? and more... 2013-06-08 12:15 Big Things Are Happening at This Pharmaceutical Company and more... 2013-06-08 00:15 Soligenix: The U.S. Government May Be Eyeing This Biotech and more... 2013-06-07 12:15 Alliance Pharmaceuticals acquires rights to Novartis' Syntometrine obstetric drug and more... 2013-06-07 00:15 Unilife: Is 2013 The Tipping Point For This Pharma Stock? and more... 2013-06-06 12:15 Regeneron, Bayer reports positive Phase 3 results for Eylea and more... 2013-06-06 00:15 Celgene's Revlimid wins additional FDA lymphoma approval and more... 2013-06-05 12:15 Battleground FDA: How Wednesday's Avandia Panel Could Help Shape The Future Of Diabetes and more... 2013-06-05 00:15 Bristol-Myers' Abilify coupons prevail in health-plan lawsuit and more... 2013-06-04 12:15 Synta Pharmaceuticals: A Promising Biotech Stock for 2013 and more... 2013-06-04 00:15 Biogen MS drug scripts up 12% in week eight, says Citigroup and more... 2013-06-03 12:15 Cancer Drug Shortages Force Doctors to Ration, Delay Treatment and more... 2013-06-03 00:15 Teva on both sides in patent lawsuits and more... 2013-06-02 00:15 How a Pricey Pregnancy Medicine Made a Comeback and more... 2013-06-01 00:15 MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe